Quality-of-life scale machine learning approach to predict immunotherapy response in patients with advanced non-small cell lung cancer

QR Code

Quality-of-life scale machine learning approach to predict immunotherapy response in patients with advanced non-small cell lung cancer

BackgroundDespite immune checkpoint inhibitors(ICIs) significantly improve clinical outcomes in patients with advanced non-small cell lung cancer (aNSCLC), disease progression is inevitable. A diverse patient-reported Quality-of-life(QoL) scales were used to predict outcomes for aNSCLC patients with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Juanyan Shen, Junliang Ma, Shaolin Chen, Su-Han Jin, Junzhu Xu, Qisha Li, Chi Zhang, Xiaojing Tian, Xiaofei Chen, Fangya Tan, Markus Hecht, Benjamin Frey, Udo S. Gaipl, Hu Ma, Jian-Guo Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	quality of life consensus clustering atezolizumab NSCLC overall survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1600265/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical efficacy and safety of anti-PD-1/PD-L1 treatments in non-small cell lung cancer (NSCLC)
by: Tian Zeng, et al.
Published: (2019-12-01)

Retrospective Multicentre Real-Life Study Evaluating the Efficacy of Atezolizumab Combined with Bevacizumab for the Treatment of Metastatic Hepatocellular Carcinoma: HIREAL Study
by: Barbe-Richaud JB, et al.
Published: (2025-07-01)

Development and validation of an explainable machine learning model for predicting postoperative pulmonary complications after lung cancer surgery: a machine learning studyResearch in context
by: Shaolin Chen, et al.
Published: (2025-08-01)

Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
by: Jie Dai, et al.
Published: (2025-01-01)

E3 ubiquitin-protein ligase CBL inhibits non-small cell lung cancer progression via ubiquitination and degradation of KDR
by: Zhiyue Tu, et al.
Published: (2025-06-01)

Two cases of unresectable hepatocellular carcinoma treated via atezolizumab and bevacizumab combination therapy
by: Ryosuke Tsunemitsu, et al.
Published: (2023-06-01)

Brain hemorrhage in patients with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
by: Bangju Kim, et al.
Published: (2025-06-01)

Perioperative Chemo/Immunotherapies in Lung Cancer: A Critical Review on the Value of Perioperative Sequences
by: Thoma’ Dario Clementi, et al.
Published: (2025-07-01)

Symptomatic Bradycardia Due to Alectinib in a Patient with Advanced Stage of NSCLC
by: Ceva Wicaksono Pitoyo, et al.
Published: (2022-07-01)

Combination BRAF/MEK Inhibitor Targeted Therapy and Immunotherapy (atezolizumab + vemurafenib + cobimetinib) for Metastatic Cutaneous Melanoma: Clinical Case
by: V. E. Askarov, et al.
Published: (2025-07-01)

Analyzing Blockchain Consensus Mechanisms for Internet of Things Networks
by: Maxim Melnikov, et al.
Published: (2024-03-01)

Prognostic impact of body composition and immune-nutritional status in oligometastatic NSCLC patients receiving radiotherapy
by: Zhifei Huang, et al.
Published: (2025-07-01)

Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR‐mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis
by: Shang‐Gin Wu, et al.
Published: (2025-01-01)

Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association
by: Manon Allaire, et al.
Published: (2025-10-01)

Development and validation of a nomogram for predicting immune-related thyroid dysfunction during immunotherapy in non-small cell lung cancer: a prospective cohort study in China
by: Qianjie Xu, et al.
Published: (2025-07-01)

The prognostic and clinicopathological value of HALP score in non-small cell lung cancer
by: Qin Li, et al.
Published: (2025-06-01)

Clinical Features of Infectious Conjunctivitis
by: Ubani, Udo
Published: (2011)

Acoustical spectroscopy of carbohydrate aqueous solutions: saccharides; alkyl glycosides; cyclodextrins. Part II. Association and Complexation
by: Udo KAATZE
Published: (2013-11-01)

Acoustical spectroscopy of carbohydrate aqueous solutions: saccharides; alkyl glycosides; cyclodextrins. Part I. Conformer variations
by: Udo KAATZE
Published: (2013-11-01)

Perioperative Management of Non-Small Cell Lung Cancer in the Era of Immunotherapy
by: Ulas Kumbasar, et al.
Published: (2025-06-01)

The predictive value of total body PET/CT in high PD-L1 expression and immunotherapy in advanced non-small cell lung cancer patients
by: Huibin Jin, et al.
Published: (2025-07-01)

Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy
by: S. K. Zyryanov, et al.
Published: (2023-11-01)

Concomitant Use of Analgesics and EGFR TKIs in Lung Cancer Patients: Outcomes and Perspectives From a Finnish Retrospective Register–Based Study
by: Laura S. Puuniemi, et al.
Published: (2025-07-01)

STUDI IN SILICO KOMPLEKS LIGAND-RESEPTOR EUGENOL DAUN BASIL (Ocimum basilicum L.) DENGAN RESEPTOR HER2 PADA NON-SMALL CELL LUNG CANCER (NSCLC) DENGAN KONTROL GEFITINIB
by: Martina Kurnia Rohmah
Published: (2017-09-01)

A novel radiomics model combining GTVp, GTVnd, and clinical data for chemoradiotherapy response prediction in patients with advanced NSCLC
by: Ya Li, et al.
Published: (2025-07-01)

pTNM System in Non Small Cell Lung Carcinoma
by: Heriawaty Hidajat, et al.
Published: (2008-11-01)

CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC
by: Jay M. Lee, MD, et al.
Published: (2025-08-01)

Occult Node Detection With Lobectomy Versus Segmentectomy for Stage IA NSCLC
by: Yota Suzuki, MD, et al.
Published: (2025-08-01)

Impact of Intraoperative Dexamethasone on Postoperative Complications and Long-Term Survival in Patients with Non-Small Cell Lung Cancer: A retrospective Propensity Score-Matched Study
by: Zhu W, et al.
Published: (2025-06-01)

The Effects of Silibinin Combined With EGFR‐TKIs in the Treatment of NSCLC
by: Xiaocen Wang
Published: (2025-02-01)

Management of Helicobacter pylori Infection in Europe: Focusing on the Maastricht V/Florence Consensus
by: Woon Geon Shin
Published: (2017-03-01)

PREFACE. The 1st Baltic Osseointegration Academy and Lihuanian University of Health Sciences Consensus Conference 9 - 10 September 2016, Kaunas, Lithuania
by: Gintaras Juodzbalys
Published: (2016-09-01)

The 2nd Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference 2019. Summary and Consensus Statements: Group I - Biological Aspects of Tooth Extraction, Socket Healing and Indications for Socket Preservation
by: Gintaras Juodzbalys, et al.
Published: (2019-09-01)

The 1st Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference 2016. Summary and Consensus Statements: Group I - Peri-Implantitis Aetiology, Risk Factors and Pathogenesis
by: Claudio Stacchi, et al.
Published: (2016-09-01)

PREFACE. The 2nd Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference 6 - 7 September 2019, Kaunas, Lithuania
by: Gintaras Juodzbalys
Published: (2019-09-01)

The 1st Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference 2016. Summary and Consensus Statements: Group III - Peri-Implantitis Treatment
by: Fernando Suárez-López del Amo, et al.
Published: (2016-09-01)

The 1st Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference 2016. Summary and Consensus Statements: Group II - Peri-Implantitis Diagnostics and Decision Tree
by: Tolga Fikret Tözüm, et al.
Published: (2016-09-01)

The 2nd Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference 2019. Summary and Consensus Statements: Group II - Extraction Socket Preservation Methods and Dental Implant Placement Outcomes within Grafted Sockets
by: Pablo Galindo-Moreno, et al.
Published: (2019-09-01)

Phosphodiesterase 1A physically interacts with YTHDF2 and reinforces the progression of non-small cell lung cancer
by: Chong Zhang, et al.
Published: (2025-07-01)

Immune Checkpoint Inhibitor‐Based Therapy as the First‐Line Treatment for Advanced Non‐Small Cell Lung Cancer: Efficacy, Challenges, and Future Perspectives
by: Xingxiang Pu, et al.
Published: (2025-06-01)